Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Penzel

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Oncotarget|April 23, 2016
Genetic changes of non-small cell lung cancer under neoadjuvant therapyArne Warth, Volker Endris, Albrecht Stenzinger, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Respiration; International Review of Thoracic Diseases|December 10, 2015
Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung BiopsiesMichael Kreuter, Detlef Kirsten, Thomas Bahmer, et al.
Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
Cancer Medicine|August 16, 2014
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatmentAlbrecht Stenzinger, Nicole Pfarr, Volker Endris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancerStephan Macher-Goeppinger, Sebastian Aulmann, Katrin E Tagscherer, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Translational Lung Cancer Research|December 4, 2018
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and cliniciansMichael Allgäuer, Jan Budczies, Petros Christopoulos, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Oncotarget|April 23, 2016
Genetic changes of non-small cell lung cancer under neoadjuvant therapyArne Warth, Volker Endris, Albrecht Stenzinger, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Respiration; International Review of Thoracic Diseases|December 10, 2015
Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung BiopsiesMichael Kreuter, Detlef Kirsten, Thomas Bahmer, et al.
Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
Cancer Medicine|August 16, 2014
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatmentAlbrecht Stenzinger, Nicole Pfarr, Volker Endris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancerStephan Macher-Goeppinger, Sebastian Aulmann, Katrin E Tagscherer, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Translational Lung Cancer Research|December 4, 2018
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and cliniciansMichael Allgäuer, Jan Budczies, Petros Christopoulos, et al.
Pageof 14